BACKGROUND: Assessment of health-related quality of life (HRQOL) is important for cost-effectiveness analyses, but the validity of generic HRQOL instruments has not been adequately evaluated in persons with dementia. OBJECTIVE: To evaluate the validity (including responsiveness to change) of the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3), 2 commonly used generic HRQOL measures, in patients with dementia. SUBJECTS: Four hundred eight patient-caregiver dyads in an 18-month dementia care management trial. METHODS: We assessed construct validity by evaluating correlations of proxy (caregiver)-reported HUI2 and HUI3 with the Blessed Dementia Rating Scale, the Charlson Comorbidity Index, and a behavior rating scale. Responsiveness was estimated using effect size (ES) statistics for behavior scale change (unchanged, small, medium, large change) and for residential status change (home to skilled nursing facility), as a global external change criterion. RESULTS: The HUI2 and HUI3 were responsive to behavioral worsening (multiattribute ES range: -0.48 to -0.78) and global decline (multiattribute ES range: -0.50 to -0.76), but not improvement. The HUI2 was more responsive than the HUI3. Correlations with the Blessed Dementia Rating Scale (r = -0.69 with both HUI2 and HUI3 multiattribute scores) and behavior scale (r = 0.44 and 0.41, respectively, for HUI2 and HUI3 multiattribute scores) supported the validity of the HUI in patients with dementia. CONCLUSIONS: Our results support the construct validity of the proxy-rated HUI2/3 in patients with moderate to severe dementia, but responsiveness results were mixed. Further studies are needed of the HUI2/3's validity, including responsiveness, in patients across the full range of dementia severity, using both self and proxy report, with particular attention to the impact of general population preference weights. When possible, multiple HRQOL measures need to be used to confirm the robustness of the findings. The proxy-rated HUI should be used in patients with moderate to severe dementia, but the self-rated HUI may be appropriate for subjects with milder cognitive impairment.
BACKGROUND: Assessment of health-related quality of life (HRQOL) is important for cost-effectiveness analyses, but the validity of generic HRQOL instruments has not been adequately evaluated in persons with dementia. OBJECTIVE: To evaluate the validity (including responsiveness to change) of the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3), 2 commonly used generic HRQOL measures, in patients with dementia. SUBJECTS: Four hundred eight patient-caregiver dyads in an 18-month dementia care management trial. METHODS: We assessed construct validity by evaluating correlations of proxy (caregiver)-reported HUI2 and HUI3 with the Blessed Dementia Rating Scale, the Charlson Comorbidity Index, and a behavior rating scale. Responsiveness was estimated using effect size (ES) statistics for behavior scale change (unchanged, small, medium, large change) and for residential status change (home to skilled nursing facility), as a global external change criterion. RESULTS: The HUI2 and HUI3 were responsive to behavioral worsening (multiattribute ES range: -0.48 to -0.78) and global decline (multiattribute ES range: -0.50 to -0.76), but not improvement. The HUI2 was more responsive than the HUI3. Correlations with the Blessed Dementia Rating Scale (r = -0.69 with both HUI2 and HUI3 multiattribute scores) and behavior scale (r = 0.44 and 0.41, respectively, for HUI2 and HUI3 multiattribute scores) supported the validity of the HUI in patients with dementia. CONCLUSIONS: Our results support the construct validity of the proxy-rated HUI2/3 in patients with moderate to severe dementia, but responsiveness results were mixed. Further studies are needed of the HUI2/3's validity, including responsiveness, in patients across the full range of dementia severity, using both self and proxy report, with particular attention to the impact of general population preference weights. When possible, multiple HRQOL measures need to be used to confirm the robustness of the findings. The proxy-rated HUI should be used in patients with moderate to severe dementia, but the self-rated HUI may be appropriate for subjects with milder cognitive impairment.
Authors: Gary Naglie; George Tomlinson; Catherine Tansey; Jane Irvine; Paul Ritvo; Sandra E Black; Morris Freedman; Michel Silberfeld; Murray Krahn Journal: Qual Life Res Date: 2006-05 Impact factor: 4.147
Authors: Dennis G Fryback; Nancy Cross Dunham; Mari Palta; Janel Hanmer; Jennifer Buechner; Dasha Cherepanov; Shani A Herrington; Ron D Hays; Robert M Kaplan; Theodore G Ganiats; David Feeny; Paul Kind Journal: Med Care Date: 2007-12 Impact factor: 2.983
Authors: Martin Fortin; Catherine Hudon; Marie-France Dubois; José Almirall; Lise Lapointe; Hassan Soubhi Journal: Health Qual Life Outcomes Date: 2005-11-23 Impact factor: 3.186
Authors: Mark S Kaplan; Nathalie Huguet; David Feeny; Bentson H McFarland; Raul Caetano; Julie Bernier; Norman Giesbrecht; Lisa Oliver; Nancy Ross Journal: J Stud Alcohol Drugs Date: 2012-07 Impact factor: 2.582
Authors: Gail Mountain; Jessica Wright; Cindy L Cooper; Ellen Lee; Kirsty Sprange; Jules Beresford-Dent; Tracey Young; Stephen Walters; Katherine Berry; Tom Dening; Amanda Loban; Emily Turton; Benjamin D Thomas; Emma L Young; Benjamin J Thompson; Bethany Crawford; Claire Craig; Peter Bowie; Esme Moniz-Cook; Alexis Foster Journal: Health Technol Assess Date: 2022-05 Impact factor: 4.106
Authors: Laura N Gitlin; Catherine Verrier Piersol; Nancy Hodgson; Katherine Marx; David L Roth; Deidre Johnston; Quincy Samus; Laura Pizzi; Eric Jutkowitz; Constantine G Lyketsos Journal: Contemp Clin Trials Date: 2016-06-21 Impact factor: 2.226
Authors: Nicole R Fowler; Anthony J Perkins; Sujuan Gao; Greg A Sachs; Malaz A Boustani Journal: J Am Geriatr Soc Date: 2019-12-02 Impact factor: 5.562
Authors: Nicole R Fowler; Amanda Harrawood; Amie Frame; Anthony J Perkins; Sujuan Gao; Christopher M Callahan; Greg A Sachs; Dustin D French; Malaz A Boustani Journal: Trials Date: 2014-06-06 Impact factor: 2.279